Kymera Therapeutics, Inc. (KYMR) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.69 | -23.8% |
| 2024 | $-2.98 | -18.3% |
| 2023 | $-2.52 | +12.2% |
| 2022 | $-2.87 | -37.3% |
| 2021 | $-2.09 | +33.7% |
| 2020 | $-3.15 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.69 | -23.8% |
| 2024 | $-2.98 | -18.3% |
| 2023 | $-2.52 | +12.2% |
| 2022 | $-2.87 | -37.3% |
| 2021 | $-2.09 | +33.7% |
| 2020 | $-3.15 | — |